Clinical Trial Search

Primary: DNA Hypomethylation and Re-expression of Silenced Tumor Suppressor Genes When Stratified for Low or High Expression of mir29

Primary: The Difference Between Pre- and 120 Minute Post-prandial Blood Glucose Concentrations at Lunch. — 146.69; 143.68; 149.02 mg/dl — p=.971

Primary: Wong-Baker FACES Pain Rating Scale — 3; 3; 4; 4 units on a scale — p=0.004

Primary: Percentage of Participants With Adverse Events — 35.4; 43.5 Percentage of participants

Primary: Ipsilateral Ischemic Stroke Before Carotid Endarterectomy — 33 participants

Primary: Percentage of Participants Who Experienced at Least 1 Adverse Event. — 80.0 Percentage of participants

Primary: Soft Tissue Thickness Over the Implant — 0.6; 0.4 mm

Primary: Tobacco Abstinence at 12 Weeks — 8; 5 participants

Primary: First "Six Minute Step Test" Performance — 166.4; 114.0; 76.6 steps

Primary: Percentage of Participants Achieving American College of Rheumatology Score 20 Percent (ACR20) Response — 63.46; 76.15 Percentage of participants

Primary: Proportion of Subjects With Total PVD at the First Day 14 Post-injection Visit (Vitreous Detachment to the Equator) as Determined by Masked Central Reading Center (CRC)…

Primary: Change in HbA1c (Glycosylated Haemoglobin) - FAS — -0.72; -0.97 percentage of glycosylated haemoglobin

Primary: Summary Scores on the SUM8 Daily Cough and Phlegm Diary Card On the Morning of Day 4 — 12.96; 12.87; 12.71 units on a scale

Primary: Number of Participants With the Indicated Grade 4 Hematology Toxicities Following Iodine-131 Anti-B1 Antibody — 1; 1; 1; 1 participants

Primary: Insulin-stimulated Glucose Disposal Rate — 30; 34; 37; 48 µmol glucose/kg FFM/min